{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:54:26Z","timestamp":1770882866624,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.mayocp.2024.02.007","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T10:05:13Z","timestamp":1719828313000},"page":"1035-1037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Need to Define High-Dose Pharmacological Circulatory Support in Cardiogenic Shock"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-8238","authenticated-orcid":false,"given":"Saraschandra","family":"Vallabhajosyula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Dawn","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navin K.","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.mayocp.2024.02.007_bib1","article-title":"Utilization of palliative care for cardiogenic shock complicating acute myocardial infarction: a 15-year national perspective on trends, disparities, predictors, and outcomes","volume":"8","author":"Vallabhajosyula","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.mayocp.2024.02.007_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008736","article-title":"Quantification of vasoactive medications and the \"pharmaco-mechanical continuum\" in cardiogenic shock","volume":"15","author":"Vallabhajosyula","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.mayocp.2024.02.007_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/SHK.0000000000001767","article-title":"Outcomes associated with norepinephrine use among cardiac intensive care unit patients with severe shock","volume":"56","author":"Burstein","year":"2021","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.mayocp.2024.02.007_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009714","article-title":"Clinician and algorithmic application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network registry","volume":"16","author":"Patel","year":"2023","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.mayocp.2024.02.007_bib5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/CCM.0000000000004815","article-title":"Differential prognostic implications of vasoactive inotropic score for patients with acute myocardial infarction complicated by cardiogenic shock according to use of mechanical circulatory support","volume":"49","author":"Choi","year":"2021","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.mayocp.2024.02.007_bib6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.chest.2017.12.021","article-title":"Management of refractory vasodilatory shock","volume":"154","author":"Jentzer","year":"2018","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.mayocp.2024.02.007_bib7","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1161\/CIR.0000000000001076","volume":"146","author":"Geller","year":"2022","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mayocp.2024.02.007_bib8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"Naidu","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2024.02.007_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.chest.2022.07.018","article-title":"The relationship between norepinephrine equivalent dose of vasopressors within 24 hours from the onset of septic shock and in-hospital mortality rate","volume":"163","author":"Sato","year":"2023","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.mayocp.2024.02.007_bib10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624000910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624000910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T10:40:01Z","timestamp":1719830401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619624000910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0025619624000910"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2024.02.007","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Need to Define High-Dose Pharmacological Circulatory Support in Cardiogenic Shock","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2024.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}